Anne Li 5/20/17
|
While studying the underpinnings of multiple sclerosis, investigators came across important clues for how to treat a very different disease: cancer. Researchers describe an antibody that can precisely target regulatory T cells which in turn unleashes the immune system to kill cancer cells. The team reports that the antibody decreased tumor growth in models of melanoma, glioblastoma and colorectal carcinoma, making it an attractive candidate for cancer immunotherapy.
See original article at: https://www.sciencedaily.com/releases/2017/05/170519151432.htm |
